Eric H. Schoenstein
Jensen Investment Management
Eric H. Schoenstein Eastman Chemical Company stake
total: 257
Jensen Investment Management EMN trades
- Total transactions:
- 17
- New positions:
- 2
- Sold out:
- 2
- Added:
- 8
- Reduced:
- 5
- Held since:
- 2015 Q3
- Held for:
- 17 quarters
- Latest activity:
- 2019 Q4
According to 2026 Q2 report, Eric H. Schoenstein doesn't hold any Eastman Chemical Company (EMN) shares. To date, the estimated cost basis is nearly $70.19 for "buy" trades and estimated average "sell" price is $79.4. Jensen Investment Management first purchased EMN in 2014 Q2, initially acquiring 5,380 shares. Eric H. Schoenstein later completely sold out the position and invested in Eastman Chemical Company again in 2015 Q3. Since the initial investment in Eastman Chemical Company (EMN), Jensen Investment Management has made 16 more transactions.
When did Eric H. Schoenstein sell Eastman Chemical Company (EMN)?
Eric H. Schoenstein sold off the entire Eastman Chemical Company (EMN) position in 2019 Q4.
When did Eric H. Schoenstein buy Eastman Chemical Company (EMN)?
Eric H. Schoenstein first invested in Eastman Chemical Company (EMN) in 2014 Q2 at the reported quarter-end price of $87.36 per share.
What's the cost basis of Jensen Investment Management's EMN stake?
The estimated cost basis for Eastman Chemical Company (EMN) stake is around $70.19 per share. This represents their average reported price* across all buy transactions
Estimated cost basis*
- Weighted AVG buy price:
- $70.19
- Weighted AVG sell price:
- $79.40
Eric H. Schoenstein's historical trades in Eastman Chemical Company
17 results
| Period |
% of portfolio |
Shares held after* |
Reported price* |
Value* |
% (shares) of activity |
% change to portfolio |
|---|---|---|---|---|---|---|
|
2019 Q4
|
0.00%
|
$73.77
|
-100% (-6,100)
|
|||
|
2019 Q1
|
0.01%
|
$75.90
|
+13.38% (+720)
|
|||
|
2018 Q3
|
0.01%
|
$95.72
|
-13.37% (-830)
|
|||
|
2018 Q2
|
0.01%
|
$100.00
|
-21.29% (-1,680)
|
|||
|
2017 Q2
|
0.01%
|
$84.03
|
+24.25% (+1,540)
|
|||
|
2017 Q1
|
0.01%
|
$80.79
|
+14.83% (+820)
|
|||
|
2016 Q4
|
0.01%
|
$75.23
|
-22.00% (-1,560)
|
|||
|
2016 Q3
|
0.01%
|
$67.70
|
+30.57% (+1,660)
|
|||
|
2016 Q2
|
0.01%
|
$67.96
|
-10.54% (-640)
|
|||
|
2016 Q1
|
0.01%
|
$72.16
|
+7.05% (+400)
|
|||
|
2015 Q4
|
0.01%
|
$67.55
|
+5.00% (+270)
|
|||
|
2015 Q3
|
0.01%
|
$64.63
|
new
|
|||
|
2015 Q2
|
0.00%
|
$69.30
|
-100% (-7,330)
|
|||
|
2015 Q1
|
0.01%
|
$69.30
|
+22.58% (+1,350)
|
|||
|
2014 Q4
|
0.01%
|
$75.92
|
-1.97% (-120)
|
|||
|
2014 Q3
|
0.01%
|
$80.82
|
+13.38% (+720)
|
|||
|
2014 Q2
|
0.01%
|
$87.36
|
new
|
|||
* Shares, change to shares, sold shares, shares held after: split-adjusted.
* Reported price: this doesn't represent the actual buy or sell price. It is the split-adjusted price of the security as of the last day of the reported period.
If the security is completely sold out, we show the reported split-adjusted price prior to the actual period.
If the security is completely sold out, we show the reported split-adjusted price prior to the actual period.
* Estimated cost basis: based on "Reported price*" (not earlier than 2013 Q2). Calculation starts from the latest "new buy" activity to the latest "close out" activity (if any).
* Value or Price: If the security is completely sold out, we show the reported value (or price) prior to the actual period.
* New buy or own: this means there is no earlier reporting (for us or in general). So we can't know if the actual purchase of the security happened at the reported period or earlier.